Author

Pablo Táboas

Hospital Sant Joan de Déu BarcelonaORCID 0000-0003-4972-677XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

Florencia Cidre‐AranaziD· 2 shared Thomas G. P. GrünewaldiD· 2 shared Tobias FaehlingiD· 2 shared Alina Ritter· 1 shared Ana BanitoiD· 1 shared Annika Jeschke· 1 shared Berta Estrada-Bes· 1 shared Carla Ríos-AstorchiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Florencia Cidre‐AranazORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJun 8, 2026

USP7 sustains PAX3::FOXO1 enhancer reprogramming and represents a therapeutic vulnerability in Rhabdomyosarcoma

Pablo Táboas, Enrique Blanco, Estela Prada…·Sara Sánchez-Molina

This study identifies USP7 as a critical regulator of PAX3::FOXO1 enhancers in FP-RMS and shows its inhibition reduces tumor growth.

DOI 10.64898/2026.06.03.724934

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 7, 2025

Targeting CXADR-mediated AKT signaling suppresses tumorigenesis and enhances chemotherapy efficacy in Ewing sarcoma

Alina Ritter, Malenka Zimmermann, Florian H. Geyer…·Florencia Cidre‐Aranaz

This study identifies CXADR as a driver of Ewing sarcoma metastasis and shows that targeting AKT signaling with Capivasertib enhances chemotherapy efficacy in CXADR-high tumors.

DOI 10.1101/2025.08.07.669049

humanbulk RNA-seq

𝕏 PostBluesky